Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline
Sign Up to like & getrecommendations! Published in 2019 at "Haemophilia"
DOI: 10.1111/hae.13903
Abstract: The factor VIII mimetic emicizumab (Hemlibra, Hoffmanâla Roche, Basel, Switzerland) has a novel mode of action that affects the laboratory monitoring of patients receiving this treatment. read more here.
Keywords: coagulation tests; treatment united; treatment; laboratory coagulation ... See more keywords